Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Healthcare Shares
Starpharma (ASX:SPL) share price climbs 3% on back of Vietnam launch
Share Gainers
Why Bellevue Gold, South32, Starpharma, and Tuas shares are pushing higher
Share Market News
The Starpharma (ASX: SPL) share price surges on Vietnam launch
Healthcare Shares
Starpharma (ASX:SPL) share price jumps 6% following AGM
Share Fallers
Why is the Starpharma (ASX:SPL) share price trading at 52-week lows?
Healthcare Shares
Starpharma (ASX:SPL) share price lifts on supply and distribution deal
Share Gainers
Why Fletcher Building, Magellan, Sezzle, & Starpharma are racing higher
Share Gainers
Here's why the Starpharma (ASX:SPL) share price is charging 4% higher today
Healthcare Shares
These were the best performing ASX biotech shares in September
Share Market News
Starpharma (ASX:SPL) share price surges 5% on United States patent news
Share Gainers
Why Accent, Calix, Pilbara Minerals, & Starpharma shares are racing higher
Earnings Results
Starpharma (ASX:SPL) share price tanks 3% on 67% revenue drop
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
